175982-83-9 Usage
Uses
Used in Pharmaceutical Industry:
Tetrahydro-4-methoxy-2H-pyran-4-ol is used as a potential anti-cancer agent for its ability to inhibit the growth of cancer cells. It has demonstrated promising results in preclinical studies, making it a candidate for further development as a therapeutic agent.
Used in Cancer Research:
Tetrahydro-4-methoxy-2H-pyran-4-ol is used in cancer research to explore its potential for the treatment of various types of cancer. Its unique structure and mechanism of action provide a basis for investigating its efficacy and safety in treating cancer.
Used in Drug Development:
Tetrahydro-4-methoxy-2H-pyran-4-ol is used in drug development to create novel treatment options for cancer patients. Its potential as a therapeutic agent is being further explored through ongoing research to understand its full capabilities and potential side effects.
Check Digit Verification of cas no
The CAS Registry Mumber 175982-83-9 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,7,5,9,8 and 2 respectively; the second part has 2 digits, 8 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 175982-83:
(8*1)+(7*7)+(6*5)+(5*9)+(4*8)+(3*2)+(2*8)+(1*3)=189
189 % 10 = 9
So 175982-83-9 is a valid CAS Registry Number.
175982-83-9Relevant articles and documents
Inhibitors of leukotriene B4. Synthesis and SAR of new β-enaminoester open-chain analogues of Zeneca ZD2138
Bird,Olivier
, p. 515 - 520 (2007/10/03)
A series of methoxy tetrahydropyranyl β-enaminoester has been discovered as inhibitors of LTB4 production. These are unusual open chain analogues of Zeneca ZD2138, the highly potent orally active 5-LO inhibitor under development for the treatment of asthma and rheumatoid arthritis. In vitro, compound 1a inhibited LTB4 formation in human whole blood with an IC50 of 0.04 μM. In inflamed exudate in the rat 1a inhibited formation of LTB4 with an oral ED50 3h after dosing of 3.0 mg/kg.
